New research has found that nearly 137 million adults—or more than half of all U.S. adults—are eligible for semaglutide ...

Discover how recaticimab delivers significant LDL-C reduction with extended 12-week dosing, enhancing lipid-lowering therapy ...

There is a growing consumer interest in alternative proactive solutions for cardiovascular disease (CVD), as evidenced by the ...

The observed changes were favorable, but results may have been affected by better-than-normal care in the control arm.

Dr Eric Berg DC, who is known as The Knowledge Doc, has shared the 'amazing benefits' of taking half a teaspoon of a superfood that reduces cholesterol and can be found in your kitchen cupboard ...

At AHA, Phase 2 results from Eli Lilly and Silence Therapeutics are seen as signs of a "major new path" of cardiovascular ...

Don't screen everyone, but rather the right ones For the early detection of familial hypercholesterolaemia, IQWiG recommends discussing cascade screening based on affected relatives. English translati ...

In the trial, 20% of patients didn’t respond well to the PCSK9 inhibitor—could genetic markers be used to tailor therapy?

The German Institute for Quality and Efficiency in Health Care (IQWiG) was commissioned by the Federal Joint Committee (G-BA) to assess the benefit of universal blood lipid screening for the early ...

USA: A recent post hoc analysis of the ORAL Surveillance trial has highlighted the essential role of statins in mitigating major adverse cardiovascular events (MACE) among patients with rheumatoid ...

Like a fire alarm sending signals to evacuate a smoky building, the immune system has internal guards to help the body sense ...

A study was conducted to determine the association between housing unaffordability and health outcomes and medication ...